Prognostic factors in inflammatory breast cancer and therapeutic implications
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (7), 921-927
- https://doi.org/10.1016/0959-8049(94)90115-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Diseases of the BreastMayo Clinic Proceedings, 1996
- Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolutionCancer, 1989
- Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced diseaseCancer, 1989
- Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservationCancer, 1988
- Inflammatory Breast CarcinomaArchives of Surgery, 1987
- Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysisCancer, 1987
- Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase ii study of 25 cases with a median follow-up of 35 monthsCancer, 1986
- Management of inflammatory carcinoma of breast with combined modality approach—an updateCancer, 1981
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978
- The Institut’s Contribution to the Definition of Factors Guiding the Choice of TreatmentPublished by Springer Nature ,1970